| Bioactivity | IPG7236 is a selective CCR8 antagonist. IPG7236 exhibits significant tumor suppression in a mouse xenograft model of human breast cancer. IPG7236 can be used in cancer research[1]. |
| Target | CCR8. |
| Name | IPG7236 |
| CAS | 2756350-91-9 |
| Formula | C23H31N3O3S |
| Molar Mass | 429.58 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wu Y, et al. Discovery of a Potent and Selective CCR8 Small Molecular Antagonist IPG7236 for the Treatment of Cancer. J Med Chem. 2023 Apr 13;66(7):4548-4564. |
IPG7236
CAS: 2756350-91-9 F: C23H31N3O3S W: 429.58
IPG7236 is a selective CCR8 antagonist. IPG7236 exhibits significant tumor suppression in a mouse xenograft model of hum
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.